# Hurco Companies Inc: financial statements, quarterly

HURC · Nasdaq · CIK 315374 · [Technology](/sectors/technology.md) · fiscal year ends Oct 31

Pages: [Overview](/companies/hurc.md) · [Financials](/companies/hurc/financials.md) · [Filings](/companies/hurc/filings.md) · [Insiders](/companies/hurc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hurc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-10-31) | Q1 FY2024 (2024-01-31) | Q2 FY2024 (2024-04-30) | Q3 FY2024 (2024-07-31) | Q4 FY2024 (2024-10-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | Q4 FY2025 (2025-10-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [66.1](/filings/0001558370-24-000115.md) | [45.1](/filings/0001558370-25-002497.md) | [45.2](/filings/0001558370-25-008487.md) | [42.7](/filings/0001558370-25-011897.md) | [53.7 d](/filings/0001104659-26-002512.md) | [46.4](/filings/0001104659-26-024614.md) | [40.9](/filings/0001104659-26-070920.md) | [45.8](/filings/0001104659-26-105453.md) | [45.5 d](/filings/0001104659-26-002512.md) | [42.9](/filings/0001104659-26-024614.md) | [47.6](/filings/0001104659-26-070920.md) | [47.3](/filings/0001104659-26-105453.md) |
| Cost of revenue | $m | [48.7 d](/filings/0001104659-26-002512.md) | [35.4](/filings/0001558370-25-002497.md) | [37.2](/filings/0001558370-25-008487.md) | [34.8](/filings/0001558370-25-011897.md) | [41.5 d](/filings/0001104659-26-002512.md) | [38.1](/filings/0001104659-26-024614.md) | [33.0](/filings/0001104659-26-070920.md) | [36.7](/filings/0001104659-26-105453.md) | [37.7 d](/filings/0001104659-26-002512.md) | [34.9](/filings/0001104659-26-024614.md) | [37.3](/filings/0001104659-26-070920.md) | [34.1](/filings/0001104659-26-105453.md) |
| Gross profit | $m | [17.4](/filings/0001558370-24-000115.md) | [9.7](/filings/0001558370-25-002497.md) | [8.0](/filings/0001558370-25-008487.md) | [7.8](/filings/0001558370-25-011897.md) | [12.2 d](/filings/0001104659-26-002512.md) | [8.3](/filings/0001104659-26-024614.md) | [7.8](/filings/0001104659-26-070920.md) | [9.1](/filings/0001104659-26-105453.md) | [7.7 d](/filings/0001104659-26-002512.md) | [7.9](/filings/0001104659-26-024614.md) | [10.3](/filings/0001104659-26-070920.md) | [13.2](/filings/0001104659-26-105453.md) |
| Selling, general and administrative | $m | [14.0](/filings/0001558370-24-000115.md) | [11.5](/filings/0001558370-25-002497.md) | [11.5](/filings/0001558370-25-008487.md) | [10.4](/filings/0001558370-25-011897.md) | [12.7 d](/filings/0001104659-26-002512.md) | [10.4](/filings/0001104659-26-024614.md) | [10.9](/filings/0001104659-26-070920.md) | [10.8](/filings/0001104659-26-105453.md) | [11.2 d](/filings/0001104659-26-002512.md) | [11.1](/filings/0001104659-26-024614.md) | [11.1](/filings/0001104659-26-070920.md) | [10.9](/filings/0001104659-26-105453.md) |
| Operating income | $m | [3.4](/filings/0001558370-24-000115.md) | [(1.8)](/filings/0001558370-25-002497.md) | [(3.4)](/filings/0001558370-25-008487.md) | [(2.5)](/filings/0001558370-25-011897.md) | [(0.5) d](/filings/0001104659-26-002512.md) | [(2.1)](/filings/0001104659-26-024614.md) | [(3.1)](/filings/0001104659-26-070920.md) | [(1.7)](/filings/0001104659-26-105453.md) | [(3.5) d](/filings/0001104659-26-002512.md) | [(3.2)](/filings/0001104659-26-024614.md) | [(0.8)](/filings/0001104659-26-070920.md) | [2.3](/filings/0001104659-26-105453.md) |
| Interest expense | $m | [0.1 d](/filings/0001558370-24-000115.md) | [0.1](/filings/0001558370-24-002825.md) | [0.1](/filings/0001558370-24-009007.md) | [0.2](/filings/0001558370-24-012651.md) | [0.2 d](/filings/0001104659-26-002512.md) | [0.1](/filings/0001104659-26-024614.md) | [0.0](/filings/0001104659-26-070920.md) | [0.0](/filings/0001104659-26-105453.md) | [0.0 d](/filings/0001104659-26-002512.md) | [0.0](/filings/0001104659-26-024614.md) | [0.0](/filings/0001104659-26-070920.md) | [0.0](/filings/0001104659-26-105453.md) |
| Income tax | $m | [1.1](/filings/0001558370-24-000115.md) | [(0.6)](/filings/0001558370-25-002497.md) | [0.0](/filings/0001558370-25-008487.md) | [7.0](/filings/0001558370-25-011897.md) | [0.3 d](/filings/0001104659-26-002512.md) | [2.0](/filings/0001104659-26-024614.md) | [0.5](/filings/0001104659-26-070920.md) | [0.6](/filings/0001104659-26-105453.md) | [(0.2) d](/filings/0001104659-26-002512.md) | [0.5](/filings/0001104659-26-024614.md) | [0.8](/filings/0001104659-26-070920.md) | [0.4](/filings/0001104659-26-105453.md) |
| Net income | $m | [2.4](/filings/0001558370-24-000115.md) | [(1.6)](/filings/0001558370-25-002497.md) | [(3.9)](/filings/0001558370-25-008487.md) | [(9.6)](/filings/0001558370-25-011897.md) | [(1.4) d](/filings/0001104659-26-002512.md) | [(4.3)](/filings/0001104659-26-024614.md) | [(4.1)](/filings/0001104659-26-070920.md) | [(3.7)](/filings/0001104659-26-105453.md) | [(3.0) d](/filings/0001104659-26-002512.md) | [(3.5)](/filings/0001104659-26-024614.md) | [(2.4)](/filings/0001104659-26-070920.md) | [2.3](/filings/0001104659-26-105453.md) |
| Diluted EPS | $ per share | [0.36](/filings/0001558370-24-000115.md) | [(0.25)](/filings/0001558370-25-002497.md) | [(0.61)](/filings/0001558370-25-008487.md) | [(1.47)](/filings/0001558370-25-011897.md) | not reported | [(0.67)](/filings/0001104659-26-024614.md) | [(0.62)](/filings/0001104659-26-070920.md) | [(0.58)](/filings/0001104659-26-105453.md) | not reported | [(0.54)](/filings/0001104659-26-024614.md) | [(0.37)](/filings/0001104659-26-070920.md) | [0.35](/filings/0001104659-26-105453.md) |
| Basic EPS | $ per share | [0.37](/filings/0001558370-24-000115.md) | [(0.25)](/filings/0001558370-25-002497.md) | [(0.61)](/filings/0001558370-25-008487.md) | [(1.47)](/filings/0001558370-25-011897.md) | not reported | [(0.67)](/filings/0001104659-26-024614.md) | [(0.62)](/filings/0001104659-26-070920.md) | [(0.58)](/filings/0001104659-26-105453.md) | not reported | [(0.54)](/filings/0001104659-26-024614.md) | [(0.37)](/filings/0001104659-26-070920.md) | [0.35](/filings/0001104659-26-105453.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-10-31) | Q1 FY2024 (2024-01-31) | Q2 FY2024 (2024-04-30) | Q3 FY2024 (2024-07-31) | FY2024 (2024-10-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | FY2025 (2025-10-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [41.8](/filings/0001558370-25-000129.md) | [37.9](/filings/0001558370-24-002825.md) | [37.5](/filings/0001558370-24-009007.md) | [36.1](/filings/0001558370-24-012651.md) | [33.3](/filings/0001104659-26-002512.md) | [41.8](/filings/0001558370-25-002497.md) | [43.8](/filings/0001558370-25-008487.md) | [44.5](/filings/0001558370-25-011897.md) | [48.7](/filings/0001104659-26-105453.md) | [48.0](/filings/0001104659-26-024614.md) | [50.1](/filings/0001104659-26-070920.md) | [52.1](/filings/0001104659-26-105453.md) |
| Current assets | $m | [248](/filings/0001558370-25-000129.md) | [247](/filings/0001558370-24-002825.md) | [239](/filings/0001558370-24-009007.md) | [233](/filings/0001558370-24-012651.md) | [229](/filings/0001104659-26-002512.md) | [217](/filings/0001558370-25-002497.md) | [223](/filings/0001558370-25-008487.md) | [228](/filings/0001558370-25-011897.md) | [225](/filings/0001104659-26-105453.md) | [223](/filings/0001104659-26-024614.md) | [221](/filings/0001104659-26-070920.md) | [223](/filings/0001104659-26-105453.md) |
| Total assets | $m | [291](/filings/0001558370-25-000129.md) | [290](/filings/0001558370-24-002825.md) | [281](/filings/0001558370-24-009007.md) | [272](/filings/0001558370-24-012651.md) | [269](/filings/0001104659-26-002512.md) | [256](/filings/0001558370-25-002497.md) | [262](/filings/0001558370-25-008487.md) | [269](/filings/0001558370-25-011897.md) | [264](/filings/0001104659-26-105453.md) | [262](/filings/0001104659-26-024614.md) | [259](/filings/0001104659-26-070920.md) | [260](/filings/0001104659-26-105453.md) |
| Current liabilities | $m | [55.0](/filings/0001558370-25-000129.md) | [50.8](/filings/0001558370-24-002825.md) | [51.4](/filings/0001558370-24-009007.md) | [51.2](/filings/0001558370-24-012651.md) | [47.8](/filings/0001104659-26-002512.md) | [44.0](/filings/0001558370-25-002497.md) | [47.0](/filings/0001558370-25-008487.md) | [51.5](/filings/0001558370-25-011897.md) | [52.0](/filings/0001104659-26-105453.md) | [53.2](/filings/0001104659-26-024614.md) | [54.4](/filings/0001104659-26-070920.md) | [56.0](/filings/0001104659-26-105453.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [222](/filings/0001104659-26-002512.md) | [225](/filings/0001558370-25-008487.md) | [216](/filings/0001558370-25-011897.md) | [207](/filings/0001558370-25-011897.md) | [207](/filings/0001104659-26-105453.md) | [198](/filings/0001104659-26-070920.md) | [202](/filings/0001104659-26-105453.md) | [204](/filings/0001104659-26-105453.md) | [199](/filings/0001104659-26-105453.md) | [195](/filings/0001104659-26-070920.md) | [192](/filings/0001104659-26-105453.md) | [192](/filings/0001104659-26-105453.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-10-31) | Q1 FY2024 (2024-01-31) | Q2 FY2024 (2024-04-30) | Q3 FY2024 (2024-07-31) | Q4 FY2024 (2024-10-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | Q4 FY2025 (2025-10-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [3.4 d](/filings/0001104659-26-002512.md) | [(2.6)](/filings/0001558370-25-002497.md) | [1.9](/filings/0001558370-25-008487.md) | [(0.6)](/filings/0001558370-25-011897.md) | [(1.2) d](/filings/0001104659-26-002512.md) | [10.3](/filings/0001104659-26-024614.md) | [1.0](/filings/0001104659-26-070920.md) | [2.5](/filings/0001104659-26-105453.md) | [3.7 d](/filings/0001104659-26-002512.md) | [(0.6)](/filings/0001104659-26-024614.md) | [2.1](/filings/0001104659-26-070920.md) | [3.8](/filings/0001104659-26-105453.md) |
| Capital expenditure | $m | [0.5 d](/filings/0001104659-26-002512.md) | [0.4](/filings/0001558370-25-002497.md) | [0.1](/filings/0001558370-25-008487.md) | [0.2](/filings/0001558370-25-011897.md) | [0.4 d](/filings/0001104659-26-002512.md) | [0.1](/filings/0001104659-26-024614.md) | [0.3](/filings/0001104659-26-070920.md) | [0.5](/filings/0001104659-26-105453.md) | [0.0 d](/filings/0001104659-26-002512.md) | [0.1](/filings/0001104659-26-024614.md) | [0.2](/filings/0001104659-26-070920.md) | [0.3](/filings/0001104659-26-105453.md) |
| Dividends paid | $m | [1.0 d](/filings/0001104659-26-002512.md) | [1.0](/filings/0001558370-25-002497.md) | [1.1](/filings/0001558370-25-008487.md) | [0.0 d](/filings/0001558370-25-011897.md) | [0.0 d](/filings/0001104659-26-002512.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q1 FY2023 (2023-01-31) | Q2 FY2023 (2023-04-30) | Q3 FY2023 (2023-07-31) | Q1 FY2024 (2024-01-31) | Q2 FY2024 (2024-04-30) | Q3 FY2024 (2024-07-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [6,622](/filings/0001558370-24-002825.md) | [6,516](/filings/0001558370-24-009007.md) | [6,469](/filings/0001558370-24-012651.md) | [6,483](/filings/0001558370-25-002497.md) | [6,518](/filings/0001558370-25-008487.md) | [6,513](/filings/0001558370-25-011897.md) | [6,459](/filings/0001104659-26-024614.md) | [6,500](/filings/0001104659-26-070920.md) | [6,463](/filings/0001104659-26-105453.md) | [6,425](/filings/0001104659-26-024614.md) | [6,473](/filings/0001104659-26-070920.md) | [6,497](/filings/0001104659-26-105453.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 6,476,322 at 2026-08-31, from the cover of the [10-Q filed 2026-09-04](/filings/0001104659-26-105453.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.